⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001814695

Wadlinger Mary E.

Reports to the SEC for 2 companies · UTRECHT, P7

Transactions

11

Companies

2

Filings

6

CIK

0001814695

Forms 4 and 5

Insider transactions

11 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-11-13	LAVA Therapeutics NVShare Options (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33.4K sh	—	—	0
2025-02-13	LAVA Therapeutics NVCommon Shares (Right to Buy)A Award	Director	AAward	+33.4K sh	—	—	33,390
2022-02-23	Forma Therapeutics Holdings, Inc.S Sale	See Remarks	SSale	−4,684 sh	$9.78	−$45.8K	134,521
2021-02-26	Forma Therapeutics Holdings, Inc.A Award	See Remarks	AAward	+14.3K sh	—	—	129,875
2021-02-26	Forma Therapeutics Holdings, Inc.A Award	See Remarks	AAward	+9,330 sh	—	—	139,205
2021-02-26	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+43.6K sh	—	—	43,550
2020-06-23	Forma Therapeutics Holdings, Inc.P Purchase	See Remarks	PPurchase	+116K sh	—	—	115,575
2020-06-23	Forma Therapeutics Holdings, Inc.S Sale	See Remarks	SSale	−91.9K sh	—	—	0
2020-06-23	Forma Therapeutics Holdings, Inc.S Sale	See Remarks	SSale	−23.4K sh	—	—	0
2020-06-23	Forma Therapeutics Holdings, Inc.S Sale	See Remarks	SSale	−29.2K sh	—	—	0
2020-06-18	Forma Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+23.4K sh	—	—	0

Recent filings

6

Accepted (ET)
Nov 174
Wadlinger Mary E.0001814695-25-000005
SEC(opens sec.gov)
Feb 184
Wadlinger Mary E.0001415889-25-004531
SEC(opens sec.gov)
Feb 254
Wadlinger Mary E.0000899243-22-007909
SEC(opens sec.gov)
Mar 24
Wadlinger Mary E.0000899243-21-009156
SEC(opens sec.gov)
Jun 244
Wadlinger Mary E.0000899243-20-017606
SEC(opens sec.gov)
Jun 224
Wadlinger Mary E.0000899243-20-017435
SEC(opens sec.gov)

Companies

2

Address

C/O LAVA THERAPEUTICS N.V. YALELAAN 62

UTRECHT, P7, 3584 CM